Fingerprint
Dive into the research topics of 'Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically